The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions

Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 16; p. 1597053
Main Authors Brown, Rebecca J., Akinci, Baris, Al Yaarubi, Saif, Bismuth, Elise, Cappa, Marco, Deeb, Asma, Kamrath, Clemens, Musso, Carla, Patni, Nivedita, Prodam, Flavia, Williams, Rachel, Wabitsch, Martin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.08.2025
Subjects
Online AccessGet full text
ISSN1664-2392
1664-2392
DOI10.3389/fendo.2025.1597053

Cover

Abstract Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases. The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes. Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored. The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.
AbstractList IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.MethodsThe clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.ResultsOur patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.DiscussionThe cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.
Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.MethodsThe clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.ResultsOur patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.DiscussionThe cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.
Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases. The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes. Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored. The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.
Author Cappa, Marco
Williams, Rachel
Wabitsch, Martin
Musso, Carla
Patni, Nivedita
Prodam, Flavia
Akinci, Baris
Brown, Rebecca J.
Bismuth, Elise
Deeb, Asma
Al Yaarubi, Saif
Kamrath, Clemens
AuthorAffiliation 3 Oman Medical Specialty Board , Muscat ,  Oman
4 Department of Pediatric Endocrinology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital , Paris ,  France
9 Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas (UT) Southwestern Medical Center , Dallas, TX ,  United States
6 Division of Paediatric Endocrine, Sheikh Shakhbout Medical City and College of Medicine and Health Sciences, Khalifa University , Abu Dhabi ,  United Arab Emirates
11 Cambridge University Hospitals, National Health Service (NHS) Foundation Trust , Cambridge ,  United Kingdom
10 Unit of Endocrinology, Department of Health Sciences, University of Eastern Piedmont , Novara ,  Italy
1 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD ,  United States
5 Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) , Rome ,  Italy
8 Hosp
AuthorAffiliation_xml – name: 12 Nottingham Children’s Hospital , Nottingham ,  United Kingdom
– name: 3 Oman Medical Specialty Board , Muscat ,  Oman
– name: 13 German Center for Child and Adolescent Health (DZKJ), Ulm Site, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center , Ulm ,  Germany
– name: 6 Division of Paediatric Endocrine, Sheikh Shakhbout Medical City and College of Medicine and Health Sciences, Khalifa University , Abu Dhabi ,  United Arab Emirates
– name: 4 Department of Pediatric Endocrinology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital , Paris ,  France
– name: 7 Centre of Child and Adolescent Medicine, Department of General Pediatrics and Neonatology, University Hospital Freiburg , Freiburg ,  Germany
– name: 9 Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas (UT) Southwestern Medical Center , Dallas, TX ,  United States
– name: 10 Unit of Endocrinology, Department of Health Sciences, University of Eastern Piedmont , Novara ,  Italy
– name: 11 Cambridge University Hospitals, National Health Service (NHS) Foundation Trust , Cambridge ,  United Kingdom
– name: 1 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD ,  United States
– name: 8 Hospital Universitario Fundación Favaloro , Ciudad Autónoma de Buenos Aires ,  Argentina
– name: 2 Department of Technological Research, Izmir Biomedicine and Genome Center, Dokuz Eylül University , Izmir ,  Türkiye
– name: 5 Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) , Rome ,  Italy
Author_xml – sequence: 1
  givenname: Rebecca J.
  surname: Brown
  fullname: Brown, Rebecca J.
– sequence: 2
  givenname: Baris
  surname: Akinci
  fullname: Akinci, Baris
– sequence: 3
  givenname: Saif
  surname: Al Yaarubi
  fullname: Al Yaarubi, Saif
– sequence: 4
  givenname: Elise
  surname: Bismuth
  fullname: Bismuth, Elise
– sequence: 5
  givenname: Marco
  surname: Cappa
  fullname: Cappa, Marco
– sequence: 6
  givenname: Asma
  surname: Deeb
  fullname: Deeb, Asma
– sequence: 7
  givenname: Clemens
  surname: Kamrath
  fullname: Kamrath, Clemens
– sequence: 8
  givenname: Carla
  surname: Musso
  fullname: Musso, Carla
– sequence: 9
  givenname: Nivedita
  surname: Patni
  fullname: Patni, Nivedita
– sequence: 10
  givenname: Flavia
  surname: Prodam
  fullname: Prodam, Flavia
– sequence: 11
  givenname: Rachel
  surname: Williams
  fullname: Williams, Rachel
– sequence: 12
  givenname: Martin
  surname: Wabitsch
  fullname: Wabitsch, Martin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40842493$$D View this record in MEDLINE/PubMed
BookMark eNpVkstqHDEQRUVwiB_xD2QRtMxmJnp2t7IJwSSxwZCNsxZ6lNwyGqkj9cTM36fHMzG2QFRRupwLpXuOTnLJgNAHStacD-pzgOzLmhEm11Sqnkj-Bp3RrhMrxhU7edGfosvWHshyBKFKDe_QqSCDYELxM7S9GwG7FHN0JmEzTbUYN-K5YDfG5LHJy_UlQXOQZzyZOS614cc4jzjFqfhdm2uZxt0XbHCDGqHhEnDMM9S8qEteuM40wD42t21tmbT36G0wqcHlsV6g3z--311dr25__by5-na7coKxecWHAJJaIMC6YJ2RvWKB9CQYS23og1LES6Z6ykLwUhAlOBkY81I5q0Kn-AW6OXB9MQ96qnFj6k4XE_XToNR7beocXQItwHYWVAAqgxDcWSt4NxBnXVBO9nJhfT2wpq3dgN-vo5r0Cvr6JcdR35e_mjLedZSQhfDpSKjlzxbarDfLSiAlk6Fsm-ZMdJwwxfZmH1-aPbv8_7hFwA4CV0trFcKzhBK9D4h-CojeB0QfA8L_AQEese8
Cites_doi 10.1210/clinem/dgae335
10.1126/scitranslmed.add4897
10.1186/s40842-018-0058-3
10.1016/j.cjca.2014.09.007
10.1186/s13023-019-1141-2
10.1111/cge.12623
10.1371/journal.pone.0162513
10.1210/jc.2003-031868
10.1016/j.medj.2021.04.001
10.1210/jc.2016-1005
10.1210/jc.2007-1328
10.1002/ajmg.a.63533
10.1186/s13052-020-00916-2
10.1016/j.seizure.2016.08.008
10.1097/01.md.0000111061.69212.59
10.1186/s13023-024-03173-2
10.1210/jc.2016-2466
10.1371/journal.pgen.1000874
10.1097/00005792-200303000-00007
10.1002/emmm.200900037
10.1016/j.cell.2007.11.042
10.1056/NEJMoa012437
10.1210/jc.2018-02730
10.1210/js.2019-00103
10.4274/jcrpe.galenos.2019.2019.0124
10.1016/j.molmet.2013.07.001
10.1210/jendso/bvad114.069
10.1056/nejmc2413871
10.1016/j.mrrev.2019.03.005
10.1016/j.ecl.2020.02.008
10.1210/clinem/dgab499
10.1016/j.beem.2007.04.007
10.1186/s13023-024-03084-2
10.1038/47254
10.3389/fendo.2021.803189
10.1016/S0140-6736(46)91599-1
10.1007/s40265-013-0074-7
10.1056/nejmoa1315496
10.1038/ng585
10.1111/j.1651-2227.1959.tb16421.x
10.1210/jc.84.9.3390
10.3389/fendo.2023.1250203
10.1038/ng0398-292
10.1007/BF02867054
10.1016/j.metabol.2004.08.021
10.1210/jc.75.2.358
10.2337/db24-0624
10.1210/jc.87.5.2395
10.1210/clinem/dgab216
10.2337/dc23-1614
10.1016/j.ecl.2017.01.012
10.1530/eje-12-0268
10.1093/hmg/9.1.109
10.1038/s41598-023-27987-5
10.1172/jci38660
10.1210/jc.2016-3628
10.1242/dmm.042655
10.1210/jcem-14-2-193
10.1080/17446651.2020.1735360
10.1002/ajmg.a.37115
10.4158/endp.19.1.v767575m65p5mr06
10.1210/jcem.87.1.8290
10.1038/72807
10.1186/s13023-024-03245-3
10.1111/dom.15061
10.1111/dom.16175
10.1210/clinem/dgaf103
10.1056/nejmra025261
10.2337/dbi24-0018
10.1002/ajmg.a.33578
10.1210/clinem/dgad700
10.1136/jmedgenet-2013-101525
10.1210/jendso/bvab048.594
10.1210/jc.2011-1159
10.1210/jc.2017-02078
10.3389/fimmu.2018.02142
10.3389/fendo.2024.1383318
10.2337/db21-1086
10.1056/nejmoa1007487
10.1038/ng880
10.1210/jc.2016-2271
10.1210/jendso/bvab019
10.1210/jc.2019-00200
10.2147/DMSO.S130810
10.2337/dc24-2408
10.1016/j.eprac.2022.03.006
10.1007/s10048-019-00574-5
10.1038/ng.3714
10.1038/s42255-019-0095-y
10.1136/jmg.23.2.120
10.1007/s40618-018-0887-z
10.1186/s13023-020-01364-1
ContentType Journal Article
Copyright Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch.
Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch
Copyright_xml – notice: Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch.
– notice: Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fendo.2025.1597053
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_4eb6be9fe15f443cbb43680cbcf9c575
PMC12366100
40842493
10_3389_fendo_2025_1597053
Genre Journal Article
Review
Case Reports
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M~E
OK1
PGMZT
RPM
CGR
CUY
CVF
ECM
EIF
IPNFZ
M48
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c422t-38fe51be0e26fbca5792f070fab1bf7f990d529712ffd5409430822d59cb9f693
IEDL.DBID DOA
ISSN 1664-2392
IngestDate Wed Aug 27 01:28:27 EDT 2025
Sat Aug 23 05:22:14 EDT 2025
Thu Sep 04 12:30:46 EDT 2025
Thu Sep 04 05:01:47 EDT 2025
Thu Aug 14 00:10:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords acquired generalized lipodystrophy
comorbidities
congenital generalized lipodystrophy
metreleptin
adolescent
familial partial lipodystrophy
acquired partial lipodystrophy
pediatric
Language English
License Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c422t-38fe51be0e26fbca5792f070fab1bf7f990d529712ffd5409430822d59cb9f693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Review-5
content type line 23
ObjectType-Case Study-4
ObjectType-Feature-2
ObjectType-Report-3
Víctor A. Cortés, Pontificia Universidad Católica de Chile, Chile
ORCID: Asma Deeb, orcid.org/0000-0003-4090-4672; Nivedita Patni, orcid.org/0000-0002-5926-7784; Flavia Prodam, orcid.org/0000-0001-9660-5335; Martin Wabitsch, orcid.org/0000-0001-6795-8430
Reviewed by: Alexander Bartelt, Ludwig Maximilian University of Munich, Germany
Toru Kusakabe, National Hospital Organization Kyoto Medical Center, Japan
Edited by: Artur Mazur, University of Rzeszow, Poland
OpenAccessLink https://doaj.org/article/4eb6be9fe15f443cbb43680cbcf9c575
PMID 40842493
PQID 3246302925
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_4eb6be9fe15f443cbb43680cbcf9c575
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12366100
proquest_miscellaneous_3246302925
pubmed_primary_40842493
crossref_primary_10_3389_fendo_2025_1597053
PublicationCentury 2000
PublicationDate 2025-08-06
PublicationDateYYYYMMDD 2025-08-06
PublicationDate_xml – month: 08
  year: 2025
  text: 2025-08-06
  day: 06
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationTitleAlternate Front Endocrinol (Lausanne)
PublicationYear 2025
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Friedman (B51) 2019; 1
Taniguchi (B77) 2016; 11
Rajab (B22) 2010; 6
Araujo-Vilar (B86) 2020; 15
Chou (B55) 2013; 73
Hussain (B68) 2018; 103
Barraquer (B4) 1907; 26
Corvillo (B41) 2018; 9
Garg (B103) 2025; 74
Simons (B10) 1911; 5
Araujo-Vilar (B14) 2019; 42
Akinci (B13) 2024; 73
Brown (B88) 2025
Farhan (B34) 2014; 30
McDuffie (B64) 2004; 89
Agarwal (B25) 2002; 87
Sánchez-Iglesias (B81) 2019; 20
Kobberling (B7) 1986; 23
Lamothe (B73) 2025
Garg (B2) 2004; 350
Seip (B9) 1959; 48
Wells (B85) 2007; 21
Garg (B18) 2015
Corvillo (B40) 2023; 72
Foss-Freitas (B72) 2024; 47
Meral (B75) 2025; 48
Chiquette (B12) 2017; 10
Altarejos (B101) 2023; 15
Haque (B48) 2002; 87
Lotta (B33) 2017; 49
Brown (B61) 2017; 102
Guillén-Navarro (B82) 2013; 50
Magre (B21) 2001; 28
Lightbourne (B63) 2021; 5
Bansal (B71) 2022; 28
Cao (B28) 2000; 9
Vatier (B95) 2019; 14
Shackleton (B31) 2000; 24
B54
B56
B57
B58
Misra (B39) 2003; 82
B59
Berardinelli (B5) 1954; 14
Donadille (B62) 2024; 19
Gavin (B84) 2020; 49
Peters (B35) 1998; 18
B100
Yildirim Simsir (B47) 2023; 25
Misra (B38) 2004; 83
Agarwal (B15) 2002; 31
Cook (B89) 2021; 5
B60
McIlroy (B78) 2020; 13
Ozen (B97) 2020; 12
Dunnigan (B6) 1974; 43
Garg (B11) 2011; 96
Blüher (B83) 2013; 2
Gandotra (B29) 2011; 364
Lightbourne (B30) 2017; 46
Cook (B90) 2021; 106
(B99) 2025
Sahinoz (B79) 2018; 4
Gupta (B46) 2017; 102
Hill (B76) 2008; 132
Lawrence (B8) 1946; 1
Akinci (B96) 2021; 2
Opri (B80) 2016; 42
Albert (B26) 2014; 370
Foss-Freitas (B37) 2020; 15
Mory (B67) 2012; 167
Akinci (B43) 2019; 104
Brown (B1) 2016; 101
Garg (B17) 1992; 75
Craveiro Sarmento (B16) 2019; 781
Oral (B49) 2002; 346
Musso (B93) 2005; 54
Lee (B92) 2019; 104
Barroso (B27) 1999; 402
Fernandez-Pombo (B45) 2023; 14
Zammouri (B53) 2021; 12
Akinci (B32) 2000
Nguyen (B94) 2021; 106
Brush (B66) 2024; 110
da Cunha Olegario (B87) 2023; 13
Rubio-Cabezas (B36) 2009; 1
Patni (B98) 2024; 19
Kim (B20) 2008; 93
Al Yaarubi (B44) 2024; 19
Kinzer (B91) 2019; 3
Garg (B19) 1999; 84
Shastry (B23) 2010
Ten (B74) 2025; 392
Akinci (B50) 2016; 101
Pedicelli (B70) 2020; 46
Olenchock (B102) 2023; 7
Fourman (B52) 2024; 15
Hayashi (B24) 2009; 119
Akinci (B65) 2024; 194
Haghighi (B69) 2016; 89
Magno (B42) 2024; 109
Handelsman (B3) 2013; 19
References_xml – volume: 110
  year: 2024
  ident: B66
  article-title: Effects of metreleptin in patients with generalized lipodystrophy before vs after the onset of severe metabolic disease
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgae335
– volume: 15
  year: 2023
  ident: B101
  article-title: Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.add4897
– volume: 4
  start-page: 6
  year: 2018
  ident: B79
  article-title: Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis
  publication-title: Clin Diabetes Endocrinol
  doi: 10.1186/s40842-018-0058-3
– volume: 30
  year: 2014
  ident: B34
  article-title: A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2014.09.007
– volume: 14
  start-page: 177
  year: 2019
  ident: B95
  article-title: Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-019-1141-2
– volume: 89
  year: 2016
  ident: B69
  article-title: Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum
  publication-title: Clin Genet
  doi: 10.1111/cge.12623
– volume: 11
  start-page: e0162513
  year: 2016
  ident: B77
  article-title: PTRF/cavin-1 deficiency causes cardiac dysfunction accompanied by cardiomyocyte hypertrophy and cardiac fibrosis
  publication-title: PloS One
  doi: 10.1371/journal.pone.0162513
– volume: 89
  year: 2004
  ident: B64
  article-title: Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031868
– volume: 2
  year: 2021
  ident: B96
  article-title: Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
  publication-title: Med
  doi: 10.1016/j.medj.2021.04.001
– volume: 101
  year: 2016
  ident: B50
  article-title: Natural history of congenital generalized lipodystrophy: A nationwide study from Turkey
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-1005
– volume: 93
  year: 2008
  ident: B20
  article-title: Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-1328
– ident: B58
– volume: 194
  start-page: e63533
  year: 2024
  ident: B65
  article-title: Metabolic and other morbid complications in congenital generalized lipodystrophy type 4
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.63533
– volume: 46
  start-page: 158
  year: 2020
  ident: B70
  article-title: Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report
  publication-title: Ital J Pediatr
  doi: 10.1186/s13052-020-00916-2
– volume: 43
  start-page: 33
  year: 1974
  ident: B6
  article-title: Familial lipoatrophic diabetes with dominant transmission. A new syndrome
  publication-title: Q J Med
– volume: 42
  start-page: 1
  year: 2016
  ident: B80
  article-title: Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review
  publication-title: Seizure
  doi: 10.1016/j.seizure.2016.08.008
– volume: 83
  start-page: 18
  year: 2004
  ident: B38
  article-title: Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature
  publication-title: Med (Baltimore)
  doi: 10.1097/01.md.0000111061.69212.59
– volume: 19
  start-page: 177
  year: 2024
  ident: B62
  article-title: Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-024-03173-2
– volume: 101
  year: 2016
  ident: B1
  article-title: The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-2466
– volume: 6
  start-page: e1000874
  year: 2010
  ident: B22
  article-title: Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations
  publication-title: PloS Genet
  doi: 10.1371/journal.pgen.1000874
– volume: 82
  year: 2003
  ident: B39
  article-title: Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature
  publication-title: Med (Baltimore)
  doi: 10.1097/00005792-200303000-00007
– volume: 1
  year: 2009
  ident: B36
  article-title: Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC
  publication-title: EMBO Mol Med
  doi: 10.1002/emmm.200900037
– volume: 132
  year: 2008
  ident: B76
  article-title: PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function
  publication-title: Cell
  doi: 10.1016/j.cell.2007.11.042
– volume: 346
  year: 2002
  ident: B49
  article-title: Leptin-replacement therapy for lipodystrophy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa012437
– volume: 104
  year: 2019
  ident: B43
  article-title: Comorbidities and survival in patients with lipodystrophy: an international chart review study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-02730
– volume: 3
  year: 2019
  ident: B91
  article-title: Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy
  publication-title: J Endocr Soc
  doi: 10.1210/js.2019-00103
– volume: 12
  start-page: 17
  year: 2020
  ident: B97
  article-title: Current diagnosis, treatment and clinical challenges in the management of lipodystrophy syndromes in children and young people
  publication-title: J Clin Res Pediatr Endocrinol
  doi: 10.4274/jcrpe.galenos.2019.2019.0124
– volume: 2
  year: 2013
  ident: B83
  article-title: Importance of estrogen receptors in adipose tissue function
  publication-title: Mol Metab
  doi: 10.1016/j.molmet.2013.07.001
– volume: 7
  year: 2023
  ident: B102
  article-title: FRI058 treatment with mibavademab, A novel leptin receptor agonist, is associated with improvement in metabolic parameters in individuals with generalized lipodystrophy
  publication-title: J Endocrine Soc
  doi: 10.1210/jendso/bvad114.069
– volume: 392
  year: 2025
  ident: B74
  article-title: Tirzepatide for congenital generalized lipodystrophy
  publication-title: N Engl J Med
  doi: 10.1056/nejmc2413871
– volume: 781
  start-page: 30
  year: 2019
  ident: B16
  article-title: The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy
  publication-title: Mutat Res Rev Mutat Res
  doi: 10.1016/j.mrrev.2019.03.005
– volume: 49
  year: 2020
  ident: B84
  article-title: Sex differences in adipose tissue function
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2020.02.008
– volume: 106
  year: 2021
  ident: B94
  article-title: Leptin attenuates cardiac hypertrophy in patients with generalized lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgab499
– volume: 21
  year: 2007
  ident: B85
  article-title: Sexual dimorphism of body composition
  publication-title: Best Pract Res Clin Endocrinol Metab
  doi: 10.1016/j.beem.2007.04.007
– volume: 19
  start-page: 118
  year: 2024
  ident: B44
  article-title: Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-024-03084-2
– volume: 402
  year: 1999
  ident: B27
  article-title: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
  publication-title: Nature
  doi: 10.1038/47254
– volume: 12
  year: 2021
  ident: B53
  article-title: Molecular and cellular bases of lipodystrophy syndromes
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2021.803189
– volume: 1
  start-page: 773
  year: 1946
  ident: B8
  article-title: Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin. (concluded)
  publication-title: Lancet
  doi: 10.1016/S0140-6736(46)91599-1
– volume: 73
  year: 2013
  ident: B55
  article-title: Metreleptin: first global approval
  publication-title: Drugs
  doi: 10.1007/s40265-013-0074-7
– volume: 370
  year: 2014
  ident: B26
  article-title: Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/nejmoa1315496
– volume: 28
  year: 2001
  ident: B21
  article-title: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
  publication-title: Nat Genet
  doi: 10.1038/ng585
– volume: 48
  year: 1959
  ident: B9
  article-title: Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome
  publication-title: Acta Paediatr (Stockh)
  doi: 10.1111/j.1651-2227.1959.tb16421.x
– volume: 84
  year: 1999
  ident: B19
  article-title: A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.84.9.3390
– volume: 14
  year: 2023
  ident: B45
  article-title: Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2023.1250203
– volume: 18
  year: 1998
  ident: B35
  article-title: Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22
  publication-title: Nat Genet
  doi: 10.1038/ng0398-292
– volume: 5
  start-page: 29
  year: 1911
  ident: B10
  article-title: Lipodystrophia progressiva
  publication-title: Z ges Neurol Psychiat
  doi: 10.1007/BF02867054
– volume: 54
  year: 2005
  ident: B93
  article-title: The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2004.08.021
– volume: 75
  year: 1992
  ident: B17
  article-title: Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.75.2.358
– volume: 74
  year: 2025
  ident: B103
  article-title: Gain of function NOTCH3 variants cause familial partial lipodystrophy due to activation of senescence pathways
  publication-title: Diabetes
  doi: 10.2337/db24-0624
– volume: 87
  start-page: 2395
  year: 2002
  ident: B48
  article-title: Serum adiponectin and leptin levels in patients with lipodystrophies
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.87.5.2395
– volume: 106
  year: 2021
  ident: B90
  article-title: Effect of leptin therapy on survival in generalized and partial lipodystrophy: A matched cohort analysis
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgab216
– ident: B57
– volume: 47
  year: 2024
  ident: B72
  article-title: Efficacy and safety of glucagon-like peptide 1 agonists in a retrospective study of patients with familial partial lipodystrophy
  publication-title: Diabetes Care
  doi: 10.2337/dc23-1614
– volume: 46
  year: 2017
  ident: B30
  article-title: Genetics of lipodystrophy
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2017.01.012
– ident: B60
– volume: 167
  year: 2012
  ident: B67
  article-title: Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje-12-0268
– volume: 26
  start-page: 1072
  year: 1907
  ident: B4
  article-title: Histoire clinique d’un cas d’atrophie du tissu celluloadipeux
  publication-title: Neurolog Zentralblatt
– volume: 9
  year: 2000
  ident: B28
  article-title: Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/9.1.109
– volume: 13
  start-page: 2176
  year: 2023
  ident: B87
  article-title: Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-27987-5
– volume: 119
  year: 2009
  ident: B24
  article-title: Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy
  publication-title: J Clin Invest
  doi: 10.1172/jci38660
– volume: 102
  year: 2017
  ident: B61
  article-title: Effects of metreleptin in pediatric patients with lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-3628
– volume: 13
  year: 2020
  ident: B78
  article-title: Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
  publication-title: Dis Model Mech
  doi: 10.1242/dmm.042655
– volume: 14
  start-page: 193
  year: 1954
  ident: B5
  article-title: An undiagnosed endocrinometabolic syndrome: report of 2 cases
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-14-2-193
– volume: 15
  start-page: 95
  year: 2020
  ident: B37
  article-title: Diagnostic strategies and clinical management of lipodystrophy
  publication-title: Expert Rev Endocrinol Metab
  doi: 10.1080/17446651.2020.1735360
– ident: B54
– ident: B59
– year: 2015
  ident: B18
  article-title: Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.37115
– volume: 19
  year: 2013
  ident: B3
  article-title: The clinical approach to the detection of lipodystrophy - an AACE consensus statement
  publication-title: Endocr Pract
  doi: 10.4158/endp.19.1.v767575m65p5mr06
– volume: 87
  year: 2002
  ident: B25
  article-title: A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.1.8290
– volume: 24
  year: 2000
  ident: B31
  article-title: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
  publication-title: Nat Genet
  doi: 10.1038/72807
– volume: 19
  start-page: 263
  year: 2024
  ident: B98
  article-title: Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-024-03245-3
– volume: 25
  year: 2023
  ident: B47
  article-title: Clinical features of generalized lipodystrophy in Turkey: A cohort analysis
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.15061
– year: 2025
  ident: B73
  article-title: Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.16175
– year: 2025
  ident: B88
  article-title: Lipodystrophy severity score to assess disease burden in lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaf103
– volume: 350
  year: 2004
  ident: B2
  article-title: Acquired and inherited lipodystrophies
  publication-title: N Engl J Med
  doi: 10.1056/nejmra025261
– volume: 73
  year: 2024
  ident: B13
  article-title: Lipodystrophy prevalence, “Lipodystrophy-like phenotypes,” and diagnostic challenges
  publication-title: Diabetes
  doi: 10.2337/dbi24-0018
– year: 2010
  ident: B23
  article-title: Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.33578
– volume: 109
  year: 2024
  ident: B42
  article-title: Clinical characteristics of patients with acquired partial lipodystrophy: A multicenter retrospective study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgad700
– volume: 50
  year: 2013
  ident: B82
  article-title: A new seipin-associated neurodegenerative syndrome
  publication-title: J Med Genet
  doi: 10.1136/jmedgenet-2013-101525
– volume: 5
  start-page: A292
  year: 2021
  ident: B63
  article-title: Long term effects of leptin on hepatic fibrosis in generalized lipodystrophy
  publication-title: J Endocr Soc
  doi: 10.1210/jendso/bvab048.594
– volume: 96
  year: 2011
  ident: B11
  article-title: Clinical review: Lipodystrophies: genetic and acquired body fat disorders
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-1159
– ident: B100
– volume: 103
  year: 2018
  ident: B68
  article-title: A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I mutation
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2017-02078
– volume: 9
  year: 2018
  ident: B41
  article-title: Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02142
– volume: 15
  year: 2024
  ident: B52
  article-title: A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2024.1383318
– ident: B56
– volume: 72
  start-page: 71
  year: 2023
  ident: B40
  article-title: Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy
  publication-title: Diabetes
  doi: 10.2337/db21-1086
– volume: 364
  year: 2011
  ident: B29
  article-title: Perilipin deficiency and autosomal dominant partial lipodystrophy
  publication-title: N Engl J Med
  doi: 10.1056/nejmoa1007487
– volume: 31
  year: 2002
  ident: B15
  article-title: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
  publication-title: Nat Genet
  doi: 10.1038/ng880
– volume: 102
  year: 2017
  ident: B46
  article-title: Clinical features and management of non-HIV-related lipodystrophy in children: A systematic review
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-2271
– volume: 5
  start-page: bvab019
  year: 2021
  ident: B89
  article-title: Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy
  publication-title: J Endocr Soc
  doi: 10.1210/jendso/bvab019
– volume: 104
  year: 2019
  ident: B92
  article-title: Effects of metreleptin on proteinuria in patients with lipodystrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2019-00200
– year: 2025
  ident: B99
  article-title: Prescribing Information
– volume: 10
  year: 2017
  ident: B12
  article-title: Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S130810
– volume-title: Lipodystrophy syndromes: presentation and treatment
  year: 2000
  ident: B32
– volume: 48
  year: 2025
  ident: B75
  article-title: Metabolic improvements with tirzepatide in lipodystrophy: A novel option
  publication-title: Diabetes Care
  doi: 10.2337/dc24-2408
– volume: 28
  year: 2022
  ident: B71
  article-title: Clinical effects of sodium-glucose transporter type 2 inhibitors in patients with partial lipodystrophy
  publication-title: Endocr Pract
  doi: 10.1016/j.eprac.2022.03.006
– volume: 20
  start-page: 73
  year: 2019
  ident: B81
  article-title: Celia’s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant
  publication-title: Neurogenetics
  doi: 10.1007/s10048-019-00574-5
– volume: 49
  start-page: 17
  year: 2017
  ident: B33
  article-title: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance
  publication-title: Nat Genet
  doi: 10.1038/ng.3714
– volume: 1
  year: 2019
  ident: B51
  article-title: Leptin and the endocrine control of energy balance
  publication-title: Nat Metab
  doi: 10.1038/s42255-019-0095-y
– volume: 23
  year: 1986
  ident: B7
  article-title: Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state
  publication-title: J Med Genet
  doi: 10.1136/jmg.23.2.120
– volume: 42
  start-page: 61
  year: 2019
  ident: B14
  article-title: Diagnosis and treatment of lipodystrophy: a step-by-step approach
  publication-title: J Endocrinol Invest
  doi: 10.1007/s40618-018-0887-z
– volume: 15
  start-page: 81
  year: 2020
  ident: B86
  article-title: LipoDDx: a mobile application for identification of rare lipodystrophy syndromes
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-020-01364-1
SSID ssj0000401998
Score 2.378782
SecondaryResourceType review_article
Snippet Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals...
IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1597053
SubjectTerms acquired generalized lipodystrophy
acquired partial lipodystrophy
Adolescent
Child
Child, Preschool
comorbidities
congenital generalized lipodystrophy
Endocrinology
familial partial lipodystrophy
Female
Humans
Lipodystrophy - diagnosis
Lipodystrophy - therapy
Male
pediatric
Title The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions
URI https://www.ncbi.nlm.nih.gov/pubmed/40842493
https://www.proquest.com/docview/3246302925
https://pubmed.ncbi.nlm.nih.gov/PMC12366100
https://doaj.org/article/4eb6be9fe15f443cbb43680cbcf9c575
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLaJIm2bxQoLfiRJYl28otCdksgfbUwN6EnnSh2CH2HvrvOyN7l90S6KUH-2DLeNA30sxIM58I-VLAmOFB1JkVuFoFViEz0pks93UEC8NM7VO2xfdy9iKe53K-cdQX5oQN9MBDx92IYEsbVAy5jEIUzlrkTGfOuqgc-Bo4-zLFNoKpNAdD2ACBxFAlA1GYuomh8Vjsx-U1WPCKyWLLEiXC_ve8zL-TJTesz_QT2RvdRno3iLtPPoTmgOx-GzfGD8kS4KarKke6IgqnfUtTtTY1DVxr8iY6sql2FJdh6a_Fa-t_d_1bC31-Sw1FtQwdbSNdbC4YUgcmj2Id7xJzZ5vuM3mZPv54mGXjiQqZE5z3WVHHIHMbWOBltM7ISvEIgz4am9tYRTBNXnJV5TxGLzH0QzYb7qVyVsVSFUdkp2mbcEJoWUcDzh7uggYBgBguuYePlHemKryakK-r3tWvA3GGhoADsdAJC41Y6BGLCblHANYtkfQ6PQBV0KMq6H-pwoRcreDTMEhw58M0oV12GrzGsmBccWhzPMC5_pVgtYAYFESot4DekmX7TbP4mYi4kbkG3E92-j-kPyMfsUdScmF5Tnb6t2W4AIent5dJt-H-NM__AB-qA74
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+approach+to+child+and+adolescent+patients+with+lipodystrophy%3A+a+series+of+international+case+discussions&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Brown%2C+Rebecca+J&rft.au=Akinci%2C+Baris&rft.au=Al+Yaarubi%2C+Saif&rft.au=Bismuth%2C+Elise&rft.date=2025-08-06&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=16&rft.spage=1597053&rft_id=info:doi/10.3389%2Ffendo.2025.1597053&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon